Scientists at Carnegie Mellon University’s Molecular Biosensor and Imaging Center have developed new “fluorogen activating proteins” (FAPs) that will become a key component of novel molecular biosensor technology being created at Carnegie Mellon. The FAPs, which can be used to monitor biological activities of individual proteins and other biomolecules within living cells in real time, are described in the February issue of Nature Biotechnology.
